ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

CINGW Cingulate Inc

0.0103
0.00 (0.00%)
2024年6月21日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Cingulate Inc CINGW NASDAQ Equity Warrant
  前日比 前日比 % 現在値 時刻
0.00 0.00% 0.0103 07:46:29
始値 安値 高値 終値 前日終値
0.0103 0.0103 0.0103 0.0103 0.0103
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/6/1906:00EDGAR2Form PRE 14A - Other preliminary proxy statements
2024/6/1821:00EDGAR2Form 8-K - Current report
2024/6/1408:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/6/1408:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/6/1408:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/6/1408:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/6/1408:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/6/1408:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/6/1306:00EDGAR2Form 8-K - Current report
2024/6/0807:00EDGAR2Form SC 13D/A - General statement of acquisition of..
2024/5/2906:54EDGAR2Form SC 13D/A - General statement of acquisition of..
2024/5/2822:20EDGAR2Form 8-K - Current report
2024/5/2413:15EDGAR2Form EFFECT - Notice of Effectiveness
2024/5/2406:01EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2024/5/2122:00GLOBEFDA Clears Cingulate to File for Marketing Approval of..
2024/5/1806:01EDGAR2Form S-1 - General form for registration of securities under..
2024/5/1321:00EDGAR2Form 8-K - Current report
2024/5/0820:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/5/0820:10EDGAR2Form 8-K - Current report
2024/5/0820:00GLOBECingulate Reports First Quarter 2024 Financial Results and..
2024/4/3018:45GLOBEPeter J. Werth, Successful Pharma Entrepreneur,..
2024/4/1706:00GLOBECingulate to Participate in Planet MicroCap Showcase: Vegas..
2024/4/0121:00GLOBECingulate Inc. Reports Fourth Quarter and Full Year 2023..
2024/3/2005:45GLOBECingulate to Participate in Benzinga All Live Access Event
2024/3/0620:45GLOBECingulate to Attend DCAT Week 2024 in New York City
2024/2/1320:45GLOBECingulate Appoints Jay Roberts, Bryan Lawrence, and Jeff..
2024/2/0706:15GLOBECingulate Announces Closing of $7.5 Million Public Offering
2024/2/0223:15GLOBECingulate Announces Pricing of $7.5 Million Public Offering
2024/1/2922:00GLOBELongtime Cingulate Controller Jennifer Callahan Promoted to..
2024/1/2920:45GLOBEWerth Family Investment Associates Converts Remaining $3.3M..
2023/12/0123:00GLOBECingulate Receives Guidance from FDA on Path Forward for..
2023/11/1406:15GLOBECingulate Inc. Reports Third Quarter 2023 Financial..
2023/10/1803:22GLOBECingulate to Host CNS Key Opinion Leader Panel in New York..
2023/9/2202:30GLOBECingulate Inc. to Present at the LD Micro Main Event XVI
2023/9/1405:15GLOBECingulate Announces Closing of $4.0 Million Public Offering
2023/9/1122:22GLOBECingulate Announces Pricing of $4.0 Million Public Offering
2023/9/1119:00GLOBECingulate Announces Detailed Trial Results from Phase 3..
2023/9/0905:31GLOBEWerth Family Investment Associates Converts $5.8 Million of..
2023/9/0521:00GLOBECingulate Announces Presentation of Full Trial Results from..
2023/8/1505:15GLOBECingulate Inc. Reports Second Quarter 2023 Financial..
2023/7/1121:00GLOBECingulate Announces Positive Top-Line Results from Phase 3..
2023/6/2921:00GLOBECingulate Successfully Manufactures Clinical Supply –..